Neurocrine Biosciences Announces Q2 Financial Results Conference Call
Neurocrine Biosciences, a biopharmaceutical company, has scheduled a conference call to discuss its second quarter 2025 financial results.
The conference call details are as follows:
- Date: To be announced
- Time: To be announced
- Format: Conference call
The company’s stock price has fluctuated within the past year, reaching a 52-week high of $157.98 USD on July 31, 2024, and a low of $84.23 USD on April 8, 2025. The current stock price stands at $133.51 USD.
Key financial metrics for Neurocrine Biosciences include:
- Price-to-earnings ratio: 43.76
- Price-to-book ratio: 5.04
Further information regarding the conference call, including the date and time, will be announced separately.